Literature DB >> 8615751

Structure-activity relationship of cytoplasmic 5'-nucleotidase substrate sites.

A C Skladanowski1, C Hoffmann, J Krass, B Jastorff, W Makarewicz.   

Abstract

Various 5'-nucleotidases (EC 3.1.3.5) exist in vertebrate tissues. The sequence and cDNA cloning of the membrane-bound ecto-5'-nucleotidase (e-N) and one of the cytosolic isoenzymes, IMP-preferring (c-N-II), but not the cytosolic AMP-preferring form (c-N-I), have been reported. While c-N-II has a broad tissue distribution, c-N-I is found only in vertebrate heart. The published data on substrate specificity involve mainly the naturally occurring nucleoside monophosphates, without a systematic structure-activity relationship study. In the present study we have used a series of AMP and IMP analogues to examine the structure-activity relationship for c-N-I and c-N-II in detail. The rank order of activity of the test compounds differed substantially between c-N-I and c-N-II. c-N-I and c-N-II varied with respect to the following interactions with substrate: (1) hydrogen-bond formation with the substituent in the 6-position of the purine ring (a donor-type with c-N-I and an acceptor-type with c-N-II); and (2) hydrophobic attraction of the 6-position unsubstituted purine ring (more pronounced with c-N-I than with c-N-II). No better substrate than 5'-AMP was found for c-N-I. We propose that c-N-I functions as an AMP-binding protein in the myocardial cell with an important role during ischaemic ATP breakdown when AMP accumulates rapidly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615751      PMCID: PMC1217106          DOI: 10.1042/bj3141001

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Mapping of the epitope/paratope interactions of a monoclonal antibody directed against adenosine 3',5'-monophosphate.

Authors:  N Nass; C Colling; M Cramer; H G Genieser; E Butt; E Winkler; L Jaenicke; B Jastorff
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

Review 2.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

3.  Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation.

Authors:  R T Smolenski; D R Lachno; S J Ledingham; M H Yacoub
Journal:  J Chromatogr       Date:  1990-05-18

4.  Evidence for existence of a cytosol 5'-nucleotidase in chicken heart: comparison of some properties of heart and liver enzymes.

Authors:  R Itoh; J Oka
Journal:  Comp Biochem Physiol B       Date:  1985

5.  Purification and characterization of bovine brain 5'-nucleotidase.

Authors:  J M Montero; J B Fes
Journal:  J Neurochem       Date:  1982-10       Impact factor: 5.372

6.  Purification and regulation of an AMP-specific cytosolic 5'-nucleotidase from dog heart.

Authors:  A Darvish; P J Metting
Journal:  Am J Physiol       Date:  1993-05

7.  Nucleoside exchange catalysed by the cytoplasmic 5'-nucleotidase.

Authors:  Y Worku; A C Newby
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

8.  Studies on the dynamic syn-anti equilibrium in purine nucleosides and nucleotides with the aid of 1H and 13C NMR spectroscopy.

Authors:  R Stolarski; C E Hagberg; D Shugar
Journal:  Eur J Biochem       Date:  1984-01-02

9.  Altered properties of human T-lymphoblast soluble low Km 5'-nucleotidase: comparison with B-lymphoblast enzyme.

Authors:  V Madrid-Marina; B Lestan; P J Nowak; I H Fox; J Spychala
Journal:  Leuk Res       Date:  1993-03       Impact factor: 3.156

10.  5'-Nucleotidase I from rabbit heart.

Authors:  Y Yamazaki; V L Truong; J M Lowenstein
Journal:  Biochemistry       Date:  1991-02-12       Impact factor: 3.162

View more
  2 in total

1.  Structural basis of the inhibition of class C acid phosphatases by adenosine 5'-phosphorothioate.

Authors:  Harkewal Singh; Thomas J Reilly; John J Tanner
Journal:  FEBS J       Date:  2011-10-10       Impact factor: 5.542

2.  Is 3'-deoxy-3'-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose?

Authors:  Sven N Reske; Sandra Deisenhofer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.